HEMOPHILIA SERVICES CONSORTIUM INC (EIN 133875950) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1997

Legal Domicile

Phone

2125856489

Tax Period

2023-07-01 to 2024-06-30

HEMOPHILIA SERVICES CONSORTIUM INC, founded in 1997, is a mid-sized nonprofit in the Health Care sector that reported $21.2M in total revenue in fiscal year 2023.

Mission

TO ENHANCE AFFORDABLE CARE TO PEOPLE WITH BLEEDING DISORDERS BY SUPPLYING BLOOD-CLOTTING CONCENTRATES & OTHER MEDICATIONS FOR THE TREATMENT OF HEMOPHILIA & OTHER BLOOD-CLOTTING DISORDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $20,898,327

Investment Income $141,163

Other Revenue $157,178

TOTAL REVENUE $21,196,668

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $20,914,887

Other Expenses $21,196,668

TOTAL EXPENSES $21,196,668

Year-over-Year Comparison

	2023	2022	Change
Revenue	$21,196,668	$21,220,888	0.0%
Expenses	$21,196,668	$21,220,888	0.0%
Net Income	$0	$0	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Colin Lahiff	Director/ VP	0.5	Officer Director	$0	$0	$0
Gregory Wuest	Director / VP (Thru 4/2024)	0.5	Officer Director	$0	$0	$0
Kevin Curtin	Director / VP	0.5	Officer Director	$0	$0	$0
Linda Mugford	Director / Secretary	2.0	Officer Director	$0	$0	$0
Mariam Voutsis	Director / President	4.0	Officer Director	$0	$0	$0
Richard Einwechter	Director / Treasurer	0.5	Officer Director	$0	$0	$0
Catherine McGuinn	Director	0.5	Director	$0	$0	$0
Christopher Fieger	Director	0.5	Director	$0	$0	$0
Christopher Walsh	Director	0.5	Director	$0	$0	$0
Edward Rogoff	Director	2.0	Director	$0	$0	$0
Helen Irving	Director	0.5	Director	$0	$0	$0
Mark Kovarik	Director	0.5	Director	$0	$0	$0
Matthew Sclafani	Director	0.5	Director	$0	$0	$0
Michael Pastier	Director	0.5	Director	$0	$0	$0
Sarah Kass	Director (Thru 1/2024)	0.5	Director	$0	$0	$0
Stephanie Meier	Director	0.5	Director	$0	$0	$0
Suchitra Acharya	Director	0.5	Director	$0	$0	$0
Michele Feldman	Assistant Treasurer	0.5	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$21,196,668	$21,196,668	$7,498,881	No data
2023	$21,220,888	$21,220,888	$7,715,828	No data
2022	$20,563,934	$20,563,934	$5,868,302	No data
2021	$17,957,787	$17,957,787	$4,510,190	No data
2020	$18,225,203	$18,225,203	$4,109,012	No data
2019	$16,580,904	$16,580,904	$2,646,866	No data
2018	$17,132,632	$17,129,736	$2,831,983	$2,896

HEMOPHILIA SERVICES CONSORTIUM INC